Wednesday, June 10, 2026

Patent directory · USPTO A61K / A61P

Patents matching “Biotherapeutics, Inc.”

156 pharma patents match "Biotherapeutics, Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 156
Index total 30,257
Page 6 / 7

Quick answer

This filtered view shows 156 pharmaceutical patents matching "Biotherapeutics, Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

156 results for “Biotherapeutics, Inc.” · 30,257 patents in full index Clear search

  1. US 10857225

    Smallpox vaccine for cancer treatment

    Calidi Biotherapeutics, Inc. · Granted Dec 8, 2020 · Expires Dec 3, 2040

    granted
  2. US 10695372

    Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy

    Iovance Biotherapeutics, Inc. · Granted Jun 30, 2020 · Expires Jun 25, 2040

    granted
  3. US 10675358

    Antibody adjuvant conjugates

    Bolt Biotherapeutics, Inc. · Granted Jun 9, 2020 · Expires Jun 4, 2040

    granted
  4. US 10653723

    Processes for production of tumor infiltrating lymphocytes and uses of the same in immunotherapy

    Iovance Biotherapeutics, Inc. · Granted May 19, 2020 · Expires May 14, 2040

    granted
  5. US 10646517

    Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy

    Iovance Biotherapeutics, Inc. · Granted May 12, 2020 · Expires May 7, 2040

    granted
  6. US 10639330

    Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy

    Iovance Biotherapeutics, Inc. · Granted May 5, 2020 · Expires Apr 30, 2040

    granted
  7. US 10611827

    Non-human primate-derived pan-ebola and pan-filovirus monoclonal antibodies directed against envelope glycoproteins

    INTEGRATED BIOTHERAPEUTICS, INC. · Granted Apr 7, 2020 · Expires Apr 2, 2040

    granted
  8. US 10537595

    Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy

    Iovance Biotherapeutics, Inc. · Granted Jan 21, 2020 · Expires Jan 16, 2040

    granted
  9. US 10517894

    Restimulation of cryopreserved tumor infiltrating lymphocytes

    Iovance Biotherapeutics, Inc. · Granted Dec 31, 2019 · Expires Dec 26, 2039

    granted
  10. US 10487140

    Targeting immunological functions to the site of bacterial infections using cell wall targeting domains of bacteriolysins

    INTEGRATED BIOTHERAPEUTICS, INC. · Granted Nov 26, 2019 · Expires Nov 21, 2039

    granted
  11. US 10463697

    Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy

    Iovance Biotherapeutics, Inc. · Granted Nov 5, 2019 · Expires Oct 31, 2039

    granted
  12. US 10420799

    Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy

    Iovance Biotherapeutics, Inc. · Granted Sep 24, 2019 · Expires Sep 19, 2039

    granted
  13. US 10415015

    Engineered artificial antigen presenting cells for tumor infiltrating lymphocyte expansion

    Iovance Biotherapeutics, Inc. · Granted Sep 17, 2019 · Expires Sep 12, 2039

    granted
  14. US 10398734

    Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy

    Iovance Biotherapeutics, Inc. · Granted Sep 3, 2019 · Expires Aug 29, 2039

    granted
  15. US 10363273

    Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy

    Iovance Biotherapeutics, Inc. · Granted Jul 30, 2019 · Expires Jul 25, 2039

    granted
  16. US 10272113

    Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy

    Iovance Biotherapeutics, Inc. · Granted Apr 30, 2019 · Expires Apr 25, 2039

    granted
  17. US 10174085

    Toxoid peptides derived from phenol soluble modulin, delta toxin, superantigens, and fusions thereof

    INTEGRATED BIOTHERAPEUTICS, INC. · Granted Jan 8, 2019 · Expires Jan 3, 2039

    granted
  18. US 10166257

    Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy

    Iovance Biotherapeutics, Inc. · Granted Jan 1, 2019 · Expires Dec 27, 2038

    granted
  19. US 10130659

    Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy

    Iovance Biotherapeutics, Inc. · Granted Nov 20, 2018 · Expires Nov 15, 2038

    granted
  20. US 10105436

    Smallpox vaccine for cancer treatment

    Calidi Biotherapeutics, Inc. · Granted Oct 23, 2018 · Expires Oct 18, 2038

    granted
  21. US 10023848

    Immunogenic composition comprising Panton-Valentine Leukocidin (PVL) derived polypeptides

    INTEGRATED BIOTHERAPEUTICS, INC. · Granted Jul 17, 2018 · Expires Jul 12, 2038

    granted
  22. US 9815872

    Toxoid peptides derived from phenol soluble modulin, delta toxin, superantigens, and fusions thereof

    INTEGRATED BIOTHERAPEUTICS, INC. · Granted Nov 14, 2017 · Expires Nov 9, 2037

    granted
  23. US 9566294

    Therapeutic and diagnostic applications based on the role of the CXCR-4 gene in tumorigenesis

    Northwest Biotherapeutics, Inc. · Granted Feb 14, 2017 · Expires Feb 9, 2037

    granted
  24. US 9556146

    Lanthionine synthetase C-like 2-based therapeutics

    Biotherapeutics, Inc. · Granted Jan 31, 2017 · Expires Jan 26, 2037

    granted